These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 1827665)

  • 1. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.
    Ryseck RP; Bravo R
    Oncogene; 1991 Apr; 6(4):533-42. PubMed ID: 1827665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.
    Macgregor PF; Abate C; Curran T
    Oncogene; 1990 Apr; 5(4):451-8. PubMed ID: 2139203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
    Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
    Hadman M; Loo M; Bos TJ
    Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
    Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A direct role for c-fos in AP-1-dependent gene transcription.
    Herrera R; Agarwal S; Walton K; Satterberg B; Distel RJ; Goodman R; Spiegelman BM; Roberts TM
    Cell Growth Differ; 1990 Oct; 1(10):483-90. PubMed ID: 2126190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrity of FOS B leucine zipper is essential for its interaction with JUN proteins.
    Ryseck RP; Kovary K; Bravo R
    Oncogene; 1990 Jul; 5(7):1091-3. PubMed ID: 2115643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-binding activity of Jun is increased through its interaction with Fos.
    Allegretto EA; Smeal T; Angel P; Spiegelman BM; Karin M
    J Cell Biochem; 1990 Apr; 42(4):193-206. PubMed ID: 2111328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR; Eubank DW; Stocco DM
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of novel, transcriptionally active AP-1 binding sites: implications for cellular transformation.
    Hawker KL; Vass JK; Ozanne BW
    Oncogene; 1996 Jul; 13(2):283-92. PubMed ID: 8710367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.